United States · FDA National Drug Code directory
Neostigmine Methylsulfate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 23155-518_f5ff3a0f-57f7-46cc-9c90-0499e02c3e7f
- Product NDC
- 23155-518
- Form
- INJECTION
- Composition / generic term
- Neostigmine Methylsulfate
- Labeler
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221125
- Source listing expiry
- 20271231
Source-listed ingredients
- NEOSTIGMINE METHYLSULFATE — 1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 CARTON (23155-518-41) / 10 mL in 1 VIAL (23155-518-31) · 23155-518-41
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →